Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

14.64
-0.7200-4.69%
Volume:1.98M
Turnover:29.33M
Market Cap:16.78B
PE:-10.10
High:15.09
Open:15.09
Low:14.61
Close:15.36
Loading ...

Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease

Benzinga
·
24 Feb

Teva, Sanofi present new results from RELIEVE UCCD Phase 2b study

TIPRANKS
·
23 Feb

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Friday Amid Ongoing Tariff Uncertainties

MT Newswires Live
·
21 Feb

Teva Pharmaceutical US Affiliate, Alvotech Selarsdi Injection Now Available in US

MT Newswires Live
·
21 Feb

Is Teva Pharmaceutical (TEVA) Trading at a Discount?

Insider Monkey
·
19 Feb

Alvotech, Teva Pharmaceutical's Bionsimlar Eye Disorder Potential Treatment Accepted for FDA Review

MT Newswires Live
·
18 Feb

Alvotech and Teva’s BLA filing for AVT06 accepted by FDA

TIPRANKS
·
18 Feb

BRIEF-Alvotech And Teva Announce Filing Acceptance Of U.S. Biologics License Application

Reuters
·
18 Feb

Alvotech Sa - Regulatory Approval Expected by Q4 2025

THOMSON REUTERS
·
18 Feb

Alvotech Sa - FDA Accepts for Review Bla for Alvotech's Biosimilar to Eylea

THOMSON REUTERS
·
18 Feb

Alvotech Sa - Regulatory Approval for Avt06 Expected by Q4 2025

THOMSON REUTERS
·
18 Feb

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for Avt06, a Proposed Biosimilar to Eylea® (Aflibercept)

THOMSON REUTERS
·
18 Feb

Stanley Druckenmiller bought Tesla and these tech stocks last quarter

Dow Jones
·
18 Feb

Teva Announces Significant Holdings Disclosure

TIPRANKS
·
16 Feb

Top Executive Unloads Massive Teva Stock Stake, Raking in Millions!

TIPRANKS
·
15 Feb

Larry Robbins' Strategic Moves: Significant Reduction in Corteva Inc. by 3.62%

GuruFocus.com
·
15 Feb